Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 1 |
GO:0031514 | motile cilium | 5 | 1 |
GO:0042995 | cell projection | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 1 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4IDA0
Term | Name | Level | Count |
---|---|---|---|
GO:0006996 | organelle organization | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0022607 | cellular component assembly | 4 | 1 |
GO:0030030 | cell projection organization | 4 | 1 |
GO:0030031 | cell projection assembly | 5 | 1 |
GO:0044782 | cilium organization | 5 | 1 |
GO:0060271 | cilium assembly | 6 | 1 |
GO:0070925 | organelle assembly | 5 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0120031 | plasma membrane bounded cell projection assembly | 6 | 1 |
GO:0120036 | plasma membrane bounded cell projection organization | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 4 |
GO:0005509 | calcium ion binding | 5 | 4 |
GO:0043167 | ion binding | 2 | 4 |
GO:0043169 | cation binding | 3 | 4 |
GO:0046872 | metal ion binding | 4 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 278 | 282 | PF00656 | 0.405 |
CLV_NRD_NRD_1 | 349 | 351 | PF00675 | 0.495 |
CLV_NRD_NRD_1 | 357 | 359 | PF00675 | 0.432 |
CLV_NRD_NRD_1 | 543 | 545 | PF00675 | 0.549 |
CLV_PCSK_FUR_1 | 347 | 351 | PF00082 | 0.467 |
CLV_PCSK_KEX2_1 | 349 | 351 | PF00082 | 0.461 |
CLV_PCSK_KEX2_1 | 548 | 550 | PF00082 | 0.472 |
CLV_PCSK_PC1ET2_1 | 548 | 550 | PF00082 | 0.554 |
CLV_PCSK_PC7_1 | 544 | 550 | PF00082 | 0.436 |
CLV_PCSK_SKI1_1 | 16 | 20 | PF00082 | 0.342 |
CLV_PCSK_SKI1_1 | 240 | 244 | PF00082 | 0.383 |
CLV_PCSK_SKI1_1 | 349 | 353 | PF00082 | 0.475 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.518 |
CLV_PCSK_SKI1_1 | 517 | 521 | PF00082 | 0.398 |
CLV_PCSK_SKI1_1 | 545 | 549 | PF00082 | 0.431 |
CLV_PCSK_SKI1_1 | 557 | 561 | PF00082 | 0.403 |
CLV_PCSK_SKI1_1 | 58 | 62 | PF00082 | 0.379 |
DEG_SPOP_SBC_1 | 290 | 294 | PF00917 | 0.707 |
DOC_CYCLIN_yCln2_LP_2 | 367 | 373 | PF00134 | 0.277 |
DOC_MAPK_DCC_7 | 363 | 373 | PF00069 | 0.284 |
DOC_MAPK_FxFP_2 | 213 | 216 | PF00069 | 0.423 |
DOC_MAPK_gen_1 | 262 | 269 | PF00069 | 0.580 |
DOC_MAPK_gen_1 | 318 | 326 | PF00069 | 0.358 |
DOC_MAPK_gen_1 | 358 | 366 | PF00069 | 0.501 |
DOC_MAPK_gen_1 | 544 | 552 | PF00069 | 0.388 |
DOC_MAPK_HePTP_8 | 88 | 100 | PF00069 | 0.396 |
DOC_MAPK_MEF2A_6 | 333 | 341 | PF00069 | 0.465 |
DOC_MAPK_MEF2A_6 | 359 | 368 | PF00069 | 0.487 |
DOC_MAPK_MEF2A_6 | 80 | 88 | PF00069 | 0.358 |
DOC_MAPK_MEF2A_6 | 91 | 100 | PF00069 | 0.397 |
DOC_PP1_MyPhoNE_1 | 30 | 37 | PF00149 | 0.526 |
DOC_PP1_RVXF_1 | 327 | 333 | PF00149 | 0.351 |
DOC_PP4_FxxP_1 | 213 | 216 | PF00568 | 0.467 |
DOC_USP7_MATH_1 | 290 | 294 | PF00917 | 0.554 |
DOC_USP7_MATH_1 | 487 | 491 | PF00917 | 0.459 |
DOC_USP7_MATH_1 | 505 | 509 | PF00917 | 0.493 |
DOC_WW_Pin1_4 | 366 | 371 | PF00397 | 0.402 |
DOC_WW_Pin1_4 | 482 | 487 | PF00397 | 0.337 |
LIG_14-3-3_CanoR_1 | 126 | 132 | PF00244 | 0.367 |
LIG_14-3-3_CanoR_1 | 144 | 152 | PF00244 | 0.441 |
LIG_14-3-3_CanoR_1 | 180 | 188 | PF00244 | 0.447 |
LIG_14-3-3_CanoR_1 | 240 | 246 | PF00244 | 0.398 |
LIG_14-3-3_CanoR_1 | 299 | 306 | PF00244 | 0.600 |
LIG_14-3-3_CanoR_1 | 517 | 522 | PF00244 | 0.417 |
LIG_Actin_WH2_2 | 164 | 182 | PF00022 | 0.424 |
LIG_Actin_WH2_2 | 543 | 559 | PF00022 | 0.440 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.553 |
LIG_BRCT_BRCA1_1 | 422 | 426 | PF00533 | 0.453 |
LIG_eIF4E_1 | 14 | 20 | PF01652 | 0.396 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.379 |
LIG_FHA_1 | 281 | 287 | PF00498 | 0.581 |
LIG_FHA_1 | 398 | 404 | PF00498 | 0.440 |
LIG_FHA_1 | 469 | 475 | PF00498 | 0.399 |
LIG_FHA_1 | 51 | 57 | PF00498 | 0.500 |
LIG_FHA_1 | 526 | 532 | PF00498 | 0.436 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.517 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.379 |
LIG_FHA_2 | 204 | 210 | PF00498 | 0.610 |
LIG_FHA_2 | 437 | 443 | PF00498 | 0.523 |
LIG_FHA_2 | 471 | 477 | PF00498 | 0.385 |
LIG_FHA_2 | 520 | 526 | PF00498 | 0.609 |
LIG_LIR_Apic_2 | 210 | 216 | PF02991 | 0.570 |
LIG_LIR_Apic_2 | 501 | 505 | PF02991 | 0.392 |
LIG_LIR_Gen_1 | 127 | 136 | PF02991 | 0.481 |
LIG_LIR_Gen_1 | 166 | 175 | PF02991 | 0.334 |
LIG_LIR_Gen_1 | 479 | 487 | PF02991 | 0.398 |
LIG_LIR_Gen_1 | 491 | 498 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 127 | 132 | PF02991 | 0.529 |
LIG_LIR_Nem_3 | 166 | 171 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 475 | 480 | PF02991 | 0.331 |
LIG_LIR_Nem_3 | 491 | 497 | PF02991 | 0.449 |
LIG_NRBOX | 363 | 369 | PF00104 | 0.369 |
LIG_PCNA_PIPBox_1 | 373 | 382 | PF02747 | 0.278 |
LIG_Pex14_2 | 457 | 461 | PF04695 | 0.319 |
LIG_SH2_CRK | 413 | 417 | PF00017 | 0.468 |
LIG_SH2_GRB2like | 8 | 11 | PF00017 | 0.473 |
LIG_SH2_NCK_1 | 481 | 485 | PF00017 | 0.315 |
LIG_SH2_NCK_1 | 8 | 12 | PF00017 | 0.462 |
LIG_SH2_SRC | 481 | 484 | PF00017 | 0.381 |
LIG_SH2_STAP1 | 255 | 259 | PF00017 | 0.553 |
LIG_SH2_STAT3 | 37 | 40 | PF00017 | 0.479 |
LIG_SH2_STAT3 | 411 | 414 | PF00017 | 0.474 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.503 |
LIG_SH2_STAT5 | 170 | 173 | PF00017 | 0.328 |
LIG_SH2_STAT5 | 255 | 258 | PF00017 | 0.550 |
LIG_SH2_STAT5 | 259 | 262 | PF00017 | 0.597 |
LIG_SH2_STAT5 | 276 | 279 | PF00017 | 0.374 |
LIG_SH2_STAT5 | 510 | 513 | PF00017 | 0.535 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.442 |
LIG_SH3_3 | 265 | 271 | PF00018 | 0.510 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.617 |
LIG_SH3_3 | 528 | 534 | PF00018 | 0.578 |
LIG_SUMO_SIM_anti_2 | 221 | 228 | PF11976 | 0.413 |
LIG_SUMO_SIM_par_1 | 221 | 228 | PF11976 | 0.425 |
LIG_SUMO_SIM_par_1 | 470 | 476 | PF11976 | 0.400 |
LIG_SUMO_SIM_par_1 | 517 | 522 | PF11976 | 0.503 |
LIG_SUMO_SIM_par_1 | 94 | 99 | PF11976 | 0.325 |
LIG_TRAF2_1 | 486 | 489 | PF00917 | 0.455 |
MOD_CK1_1 | 107 | 113 | PF00069 | 0.614 |
MOD_CK1_1 | 127 | 133 | PF00069 | 0.510 |
MOD_CK1_1 | 173 | 179 | PF00069 | 0.509 |
MOD_CK1_1 | 298 | 304 | PF00069 | 0.621 |
MOD_CK2_1 | 366 | 372 | PF00069 | 0.543 |
MOD_CK2_1 | 470 | 476 | PF00069 | 0.455 |
MOD_CK2_1 | 482 | 488 | PF00069 | 0.355 |
MOD_CK2_1 | 60 | 66 | PF00069 | 0.522 |
MOD_GlcNHglycan | 115 | 118 | PF01048 | 0.571 |
MOD_GlcNHglycan | 163 | 166 | PF01048 | 0.415 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.413 |
MOD_GlcNHglycan | 277 | 280 | PF01048 | 0.440 |
MOD_GlcNHglycan | 300 | 303 | PF01048 | 0.562 |
MOD_GlcNHglycan | 507 | 510 | PF01048 | 0.513 |
MOD_GlcNHglycan | 511 | 514 | PF01048 | 0.523 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.549 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.434 |
MOD_GSK3_1 | 199 | 206 | PF00069 | 0.542 |
MOD_GSK3_1 | 249 | 256 | PF00069 | 0.378 |
MOD_GSK3_1 | 291 | 298 | PF00069 | 0.591 |
MOD_GSK3_1 | 505 | 512 | PF00069 | 0.449 |
MOD_GSK3_1 | 56 | 63 | PF00069 | 0.473 |
MOD_GSK3_1 | 560 | 567 | PF00069 | 0.536 |
MOD_N-GLC_1 | 138 | 143 | PF02516 | 0.578 |
MOD_N-GLC_1 | 144 | 149 | PF02516 | 0.579 |
MOD_N-GLC_1 | 161 | 166 | PF02516 | 0.331 |
MOD_N-GLC_2 | 192 | 194 | PF02516 | 0.419 |
MOD_NEK2_1 | 115 | 120 | PF00069 | 0.472 |
MOD_NEK2_1 | 199 | 204 | PF00069 | 0.402 |
MOD_NEK2_1 | 225 | 230 | PF00069 | 0.425 |
MOD_NEK2_1 | 275 | 280 | PF00069 | 0.470 |
MOD_NEK2_1 | 304 | 309 | PF00069 | 0.489 |
MOD_NEK2_1 | 380 | 385 | PF00069 | 0.441 |
MOD_NEK2_1 | 397 | 402 | PF00069 | 0.404 |
MOD_NEK2_1 | 498 | 503 | PF00069 | 0.451 |
MOD_NEK2_1 | 562 | 567 | PF00069 | 0.436 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.526 |
MOD_NEK2_1 | 60 | 65 | PF00069 | 0.528 |
MOD_NEK2_2 | 527 | 532 | PF00069 | 0.630 |
MOD_PIKK_1 | 105 | 111 | PF00454 | 0.533 |
MOD_PIKK_1 | 538 | 544 | PF00454 | 0.521 |
MOD_PIKK_1 | 60 | 66 | PF00454 | 0.570 |
MOD_PIKK_1 | 89 | 95 | PF00454 | 0.469 |
MOD_PK_1 | 333 | 339 | PF00069 | 0.460 |
MOD_PKA_2 | 125 | 131 | PF00069 | 0.364 |
MOD_PKA_2 | 143 | 149 | PF00069 | 0.470 |
MOD_PKA_2 | 179 | 185 | PF00069 | 0.477 |
MOD_PKA_2 | 290 | 296 | PF00069 | 0.723 |
MOD_PKA_2 | 298 | 304 | PF00069 | 0.531 |
MOD_PKA_2 | 397 | 403 | PF00069 | 0.485 |
MOD_PKA_2 | 420 | 426 | PF00069 | 0.462 |
MOD_PKB_1 | 289 | 297 | PF00069 | 0.565 |
MOD_Plk_1 | 138 | 144 | PF00069 | 0.586 |
MOD_Plk_1 | 560 | 566 | PF00069 | 0.416 |
MOD_Plk_4 | 428 | 434 | PF00069 | 0.434 |
MOD_Plk_4 | 533 | 539 | PF00069 | 0.516 |
MOD_Plk_4 | 67 | 73 | PF00069 | 0.519 |
MOD_ProDKin_1 | 366 | 372 | PF00069 | 0.399 |
MOD_ProDKin_1 | 482 | 488 | PF00069 | 0.336 |
MOD_SUMO_for_1 | 269 | 272 | PF00179 | 0.438 |
MOD_SUMO_rev_2 | 419 | 429 | PF00179 | 0.444 |
MOD_SUMO_rev_2 | 540 | 547 | PF00179 | 0.404 |
TRG_DiLeu_BaEn_1 | 372 | 377 | PF01217 | 0.474 |
TRG_DiLeu_BaEn_1 | 514 | 519 | PF01217 | 0.434 |
TRG_DiLeu_BaLyEn_6 | 546 | 551 | PF01217 | 0.497 |
TRG_DiLeu_LyEn_5 | 514 | 519 | PF01217 | 0.434 |
TRG_ENDOCYTIC_2 | 413 | 416 | PF00928 | 0.416 |
TRG_ENDOCYTIC_2 | 481 | 484 | PF00928 | 0.316 |
TRG_ENDOCYTIC_2 | 85 | 88 | PF00928 | 0.537 |
TRG_ER_diArg_1 | 155 | 158 | PF00400 | 0.421 |
TRG_ER_diArg_1 | 288 | 291 | PF00400 | 0.719 |
TRG_ER_diArg_1 | 347 | 350 | PF00400 | 0.568 |
TRG_NES_CRM1_1 | 392 | 407 | PF08389 | 0.402 |
TRG_Pf-PMV_PEXEL_1 | 549 | 553 | PF00026 | 0.447 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HW03 | Leptomonas seymouri | 61% | 99% |
A0A0S4JII0 | Bodo saltans | 28% | 97% |
A0A1X0P3R1 | Trypanosomatidae | 44% | 100% |
A0A3Q8IJI1 | Leishmania donovani | 100% | 100% |
A0A422NKK1 | Trypanosoma rangeli | 44% | 100% |
A4HPH8 | Leishmania braziliensis | 84% | 100% |
D0A8E0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 86% |
E9AT90 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4Q1A7 | Leishmania major | 95% | 100% |
V5AU55 | Trypanosoma cruzi | 41% | 100% |